<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_adVxQE3">Do mHealth applications improve clinical outcomes of patients with cancer? A critical appraisal of the peer-reviewed literature</title>
				<funder>
					<orgName type="full">Improvement Science Fellowship of the Health Foundation</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw"># The Author(s) 2019</p>
				</availability>
				<date type="published" when="2019-07-04">4 July 2019</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Jemima</forename><surname>Osborn</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Ysbyty Gwynedd , Penrhosgarnedd , Bangor , Gwynedd LL57 2PW , UK</note>
								<orgName type="institution">Ysbyty Gwynedd</orgName>
								<address>
									<addrLine>Penrhosgarnedd</addrLine>
									<postCode>LL57 2PW</postCode>
									<settlement>Bangor</settlement>
									<region>Gwynedd</region>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anu</forename><surname>Ajakaiye</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Ysbyty Gwynedd , Penrhosgarnedd , Bangor , Gwynedd LL57 2PW , UK</note>
								<orgName type="institution">Ysbyty Gwynedd</orgName>
								<address>
									<addrLine>Penrhosgarnedd</addrLine>
									<postCode>LL57 2PW</postCode>
									<settlement>Bangor</settlement>
									<region>Gwynedd</region>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tim</forename><surname>Cooksley</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> The Christie NHS Foundation Trust , Wilmslow Rd , Manchester M20 4BX , UK</note>
								<orgName type="institution">The Christie NHS Foundation Trust</orgName>
								<address>
									<addrLine>Wilmslow Rd</addrLine>
									<postCode>M20 4BX</postCode>
									<settlement>Manchester</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><forename type="middle">P</forename><surname>Subbe</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Ysbyty Gwynedd , Penrhosgarnedd , Bangor , Gwynedd LL57 2PW , UK</note>
								<orgName type="institution">Ysbyty Gwynedd</orgName>
								<address>
									<addrLine>Penrhosgarnedd</addrLine>
									<postCode>LL57 2PW</postCode>
									<settlement>Bangor</settlement>
									<region>Gwynedd</region>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> School of Medical Sciences , Bangor University , Brigantia Building , Penrallt Road , Bangor , Gwynedd LL57 2AS , UK</note>
								<orgName type="department">School of Medical Sciences</orgName>
								<orgName type="institution">Bangor University</orgName>
								<address>
									<addrLine>Brigantia Building Penrallt Road</addrLine>
									<postCode>LL57 2AS</postCode>
									<settlement>Bangor</settlement>
									<region>Gwynedd</region>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_bRFq44Y">Do mHealth applications improve clinical outcomes of patients with cancer? A critical appraisal of the peer-reviewed literature</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2019-07-04">4 July 2019</date>
						</imprint>
					</monogr>
					<idno type="MD5">EA2FA709FEBE3BBFD31FA77BFC289A74</idno>
					<idno type="DOI">10.1007/s00520-019-04945-4</idno>
					<note type="submission">Received: 1 August 2018 / Accepted: 18 June 2019 /</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T08:49+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_FnQmUFN">Cancer</term>
					<term xml:id="_pUnF9nJ">mHealth</term>
					<term xml:id="_gsARaa4">Smartphone</term>
					<term xml:id="_G9XyptN">Internet</term>
					<term xml:id="_ch4qFU2">Health-related quality of life</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_WRpzt9P"><p xml:id="_d77DfeK"><s xml:id="_Bey4bAM">Purpose Patients undergoing systemic anti-cancer treatment experience distressing side effects, and these symptoms are often experienced outside the hospital setting.</s><s xml:id="_Y9XJyDs">The impact of usage of cancer-related mobile health (mHealth) applications on patientrelated outcomes requires investigation.</s><s xml:id="_kmeNKW4">Methods A critical appraisal of the literature was performed for the following question: 'In patients with cancer have mHealth applications been compared with usual care to examine impact on commonly used clinical outcomes'.</s><s xml:id="_TjQJ8WU">Literature searches were undertaken with the help of a research librarian and included Medline, Cochrane Collaboration, clinical trial databases and grey searches.</s></p><p xml:id="_m8jKHWU"><s xml:id="_PCMFQWv">Results Seventeen studies including between 12 and 2352 patients were identified and reviewed.</s><s xml:id="_MEYKrWm">Smartphone applications or internet portals collected data on symptoms or patient activity.</s><s xml:id="_kVMykMJ">Several studies showed statistically significant differences in patient-reported outcomes when symptom monitoring using mobile health application was compared to usual care.</s><s xml:id="_k4z5Huz">Change in mobility was the only outcome that was related directly to toxicity.</s><s xml:id="_R2vCJqR">Only limited data on mortality, cancer-related morbidity including complications of care, health-economic outcomes or long-term outcomes were reported.</s><s xml:id="_VXgubKn">Conclusions Studies on mHealth applications might improve aspects of symptom control in patients with cancer, but there is currently little evidence for impact on other outcomes.</s><s xml:id="_FwsRPJg">This requires future research in interventional studies.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_yDENcAk">Introduction</head><p xml:id="_J2XEDTg"><s xml:id="_2F24kEC">Complications of cancer and its treatments are common <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_tHFRM52">Many patients will experience side effects following chemotherapy, radiotherapy or targeted therapies.</s><s xml:id="_3R9Cejq">These lead to morbidity and mortality as well as increased resource utilisation in the community or hospital setting.</s><s xml:id="_MCmxT9q">Complications of cancer and its treatments are often predictable (fever, diarrhoea, skin reactions and drug-specific effects).</s><s xml:id="_P4TENYY">Education of patients might help to increase compliance with care pathways <ref type="bibr" target="#b1">[2]</ref> especially if tailored to an individual's needs.</s><s xml:id="_qh6tYRF">In the context of an increasingly digital healthcare system, it is therefore worth considering the role of mobile health applications (mHealth) for clinical care, patient education and safety of treatment.</s></p><p xml:id="_asdYtc2"><s xml:id="_s7xQXMh">No standardized definition of mHealth exists, but for the purpose of the Global Observatory for eHealth (GOe), mHealth or mobile health has been defined as 'medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants (PDAs), and other wireless devices' <ref type="bibr">[3]</ref>.</s><s xml:id="_FBY7cvY">There are currently 97,000 mobile health applications, and in 2017, the number of global users for these was thought to be at 3.4 billion patients <ref type="bibr" target="#b2">[4]</ref>.</s><s xml:id="_3XuTET9">The widespread use of smartphones (80% of patients <ref type="bibr" target="#b3">[5]</ref>, 95% of nurse and 99% of doctor <ref type="bibr" target="#b4">[6]</ref>) in the UK means that mHealth applications are potentially accessible by most participants in healthcare: Healthcare professionals use smartphone applications to access risk assessment tools and scoring systems or to recap guidelines.</s><s xml:id="_Y7GDQUm">Research on interventions based on mHealth applications suggests that they can be used to alter health related behaviours <ref type="bibr" target="#b5">[7]</ref>, such as medication adherence <ref type="bibr" target="#b6">[8]</ref>, but economic evidence for their usage is limited <ref type="bibr" target="#b7">[9]</ref>.</s></p><p xml:id="_23G6evb"><s xml:id="_q8JCgSn">Patients use applications to get lifestyle advice, dietary information or practice mindfulness, yoga or other sports.</s><s xml:id="_eQ9Vxeg">Mobile health applications for patients with cancer might track deterioration <ref type="bibr" target="#b8">[10]</ref> and support education and recovery <ref type="bibr" target="#b9">[11]</ref><ref type="bibr" target="#b10">[12]</ref><ref type="bibr" target="#b11">[13]</ref> and have been suggested as a topic for research <ref type="bibr" target="#b12">[14]</ref>.</s><s xml:id="_TKEnydG">It is not known how mHealth applications affect patientreported experience and patient-reported outcome measures.</s><s xml:id="_7s84EYk">The latter can be generic or cancer specific.</s><s xml:id="_rAHKK8X">Patient-related outcomes measures are thought to be central for the understanding of effectiveness of treatments in cancer, improve patient-provider communication, patient satisfaction <ref type="bibr" target="#b13">[15]</ref>, everyday life <ref type="bibr" target="#b14">[16]</ref> and survival <ref type="bibr" target="#b15">[17]</ref>.</s></p><p xml:id="_w8Wt3ce"><s xml:id="_mb8XtjM">In order to improve support of patients referred to the local oncology service that covers a large rural and remote area in North Wales, the authors reviewed the literature to identify mHealth application with a peer-reviewed evidence of impact on clinical outcomes that could be deployed in UK practice.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ktrUusP">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_haVaQSJ">Study design</head><p xml:id="_eyG5WdM"><s xml:id="_pbr4jZN">The review of the literature used the format of a 'Critically appraised topic' (CAT).</s><s xml:id="_bVbxYzA">CATs are standardized summaries which draw together best available evidence to answer questions based on real clinical scenarios <ref type="bibr" target="#b16">[18]</ref>.</s><s xml:id="_cmqNsxZ">CATs follow principles of evidence-based medicine in four steps: The authors (1) form a focused and answerable question based on a clinical encounter, (2) search for the best available evidence, (3) critically appraise the evidence for validity and clinical relevance and (4) examine the application of the results to clinical practice and future research.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_zC3dcBF">Search strategy</head><p xml:id="_9c7QmGd"><s xml:id="_93JxsJE">The search question was created in a patient-intervention-comparison-outcomes (PICO) format: 'In patients with cancer (P) have mHealth applications (I) been compared with usual care (C) to examine impact on commonly used clinical outcomes (O)'.</s></p><p xml:id="_CQDgmSD"><s xml:id="_D9C2ty3">Outcomes that are commonly used in cancer trials include mortality, morbidity, quality of life, usage of hospital beds, number of outpatient appointments or appointments in primary care.</s><s xml:id="_k3Vs6dJ">The context of care of patients with cancer morbidity related to treatments might be of particular interest.</s></p><p xml:id="_pXjbUA5"><s xml:id="_vdqUA26">A literature search was undertaken with the assistance of a research librarian.</s><s xml:id="_7uEHVur">The following search string was used: (Mobile applications 'OR' Smartphone applications) 'AND' (Cancer 'OR' Neoplasms) followed by further searching using specific outcome measures: ('morbidity' OR 'mortality' OR 'quality of life' OR 'hospital beds' OR 'patient safety' OR 'outpatient appointments' OR 'GP appointments').</s></p><p xml:id="_Vn7umzY"><s xml:id="_KYDBnq5">Additionally, a search for studies using patient portals was conducted: ("Patient Portals"[Mesh]) AND (cancer or neoplasm).</s><s xml:id="_jyNcvHZ">Identified papers were searched for further applicable references ('snow balling').</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vpherZ3">Inclusion and exclusion criteria</head><p xml:id="_4U82yU7"><s xml:id="_6qWNekG">Study criteria were agreed prior to undertaking the review: Publications up to April 2018 were included.</s><s xml:id="_HNUYbMc">No study predating 2014 was identified.</s><s xml:id="_EDbztER">Randomized and non-randomized studies on all types of cancer including haematological malignancies were included.</s><s xml:id="_MpCg6zu">The review included dedicated mobile applications as well as programs that could be used on a smartphone such as web portals.</s></p><p xml:id="_9TyhwWB"><s xml:id="_EFmKEnd">Non-patient-facing applications, research protocols, studies that did not measure clinical outcomes and studies that reported purely application feasibility were excluded.</s></p><p xml:id="_zDZMpUZ"><s xml:id="_GhrqHPe">Studies were selected by one of the investigators (JO) and confirmed by the second investigator (AA).</s><s xml:id="_aFYRhEr">The papers identified in the search were analysed using the following questions: Does the study address the research question, were the study methods valid in a generic oncology setting and are the results applicable to patients with cancer looked after in a clinical (vs research) setting.</s></p><p xml:id="_wufmEEW"><s xml:id="_bEEPCJx">Search terms were applied to Pubmed, Embase, Cochrane library and a national registry of trials (ClinicalTrials.gov).</s></p><p xml:id="_ecQPqEz"><s xml:id="_EWJZAwd">No funding was received for the undertaking of the review.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vBEr7ky">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_RHagA5F">Identified studies</head><p xml:id="_ErahXEd"><s xml:id="_tVJpBPk">The search found 139 abstracts, of which 17 fulfilled inclusion and exclusion criteria (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s xml:id="_pDVPyaH">Eighty-four studies initially identified did not meet the inclusion criteria as they did not measure a patient-related outcome or were not for direct patient use.</s></p><p xml:id="_d3AESdj"><s xml:id="_ZJnHWh3">The Cochrane Library identified a number of systematic reviews of mobile Health applications but none in the context of cancer care.</s><s xml:id="_2UMU7P3">The national database of clinical trials (ClinicalTrial.Gov) identified 72 trials; 20 of these were marked as 'completed', and two had published results in the peer-reviewed literature <ref type="bibr" target="#b17">[19,</ref><ref type="bibr" target="#b18">20]</ref>.</s></p><p xml:id="_F7cddng"><s xml:id="_ujWp45M">Seventeen studies met inclusion and exclusion criteria.</s><s xml:id="_y2cq3vB">Sample sizes varied from 12 to 2352 patients with a median of 130 patients.</s><s xml:id="_PVqJx7k">Eleven of the studies had less than 100 participants.</s><s xml:id="_42XYqWU">Ten of the studies were randomized controlled trials using usual care as their comparator.</s><s xml:id="_2CUREkm">Patients with breast cancer were the patient group most commonly targeted (6 studies) (Tables <ref type="table">1</ref>, <ref type="table" target="#tab_0">2</ref>, and 3).</s><s xml:id="_NMQMpKa">Studies examined effects of custom-built smartphone applications and internet portals as well as existing messaging services <ref type="bibr" target="#b19">[21]</ref> and patient portals <ref type="bibr" target="#b20">[22]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_a5N9HF8">Interventions delivered through mHealth applications</head><p xml:id="_z3CMXEj"><s xml:id="_MQrEkJ5">Interventions that were delivered in the studies fell into broad categories: (1) delivery of information/education in a digital format <ref type="bibr" target="#b21">[23]</ref><ref type="bibr" target="#b22">[24]</ref><ref type="bibr" target="#b23">[25]</ref>, (2) provision of lifestyle interventions such as mindfulness <ref type="bibr" target="#b17">[19]</ref>, exercise <ref type="bibr" target="#b24">[26,</ref><ref type="bibr" target="#b25">27]</ref> or consumption of vegetables <ref type="bibr" target="#b26">[28]</ref> and (3) symptom scores ranging from pain <ref type="bibr" target="#b21">[23]</ref> to psychological symptoms of posttraumatic stress disorder (PTSD) <ref type="bibr" target="#b22">[24]</ref> and usually linked to a healthcare professional for escalation <ref type="bibr" target="#b27">[29]</ref>.</s><s xml:id="_HeVMM6k">One study looking at detection of lung cancer relapse allowed patients to access follow-up and imaging sooner if concern was raised from reported symptoms <ref type="bibr" target="#b28">[30]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_HQ6cE88">Reported outcomes</head><p xml:id="_ZWGVpeT"><s xml:id="_PCsGwzY">As per our inclusion criteria, only apps which measured a patient-related outcome were included (Table <ref type="table" target="#tab_0">2</ref>).</s></p><p xml:id="_uswkYyW"><s xml:id="_bU7Q4aS">Patient symptoms Outcomes were heterogeneous, largely focusing on symptoms related to cancer and reporting severity, distress or quality of life impact related to specific symptoms.</s><s xml:id="_VJgZJc3">Quality of life measures included disease specific <ref type="bibr" target="#b25">[27]</ref> or generic <ref type="bibr" target="#b29">[31]</ref> tools.</s></p><p xml:id="_bYqww4p"><s xml:id="_FNQjctb">The main positive clinical outcome from usage of mHealth applications was significant improvement in pain intensity, pain interference and consequentially quality of life <ref type="bibr" target="#b21">[23]</ref>; nausea, fatigue, urinary symptoms and emotional functioning <ref type="bibr" target="#b30">[32]</ref>; fewer days of moderate-severe neuropathic symptoms, distress and activity interference <ref type="bibr" target="#b21">[23]</ref>; reduction in post-traumatic stress disorder symptoms <ref type="bibr" target="#b22">[24]</ref>; reductions in distress <ref type="bibr" target="#b31">[33]</ref> and less severe neuropathic pain compared to usual care <ref type="bibr" target="#b32">[34]</ref> at scheduled outpatient visits.</s><s xml:id="_PHcEmTC">Physical activity improved in two studies <ref type="bibr" target="#b18">[20,</ref><ref type="bibr" target="#b26">28]</ref>.</s><s xml:id="_CeaqxJ3">As a caveat, in several studies, symptoms were more common in the intervention group <ref type="bibr" target="#b27">[29,</ref><ref type="bibr" target="#b31">33,</ref><ref type="bibr" target="#b33">35]</ref>.</s></p><p xml:id="_9gQZD3Q"><s xml:id="_E8vJq67">Treatment toxicity A Mexican study established a correlation between reduction in day-to-day mobility and chemotherapy toxicity in geriatric cancer patients <ref type="bibr" target="#b24">[26]</ref>.</s><s xml:id="_mPmBfxS">Symptom scores could be used to optimize treatments <ref type="bibr" target="#b29">[31]</ref>.</s></p><p xml:id="_QrmKmEJ"><s xml:id="_nCYV9Fz">Mortality One of the studies has subsequently published long-term follow-up data from using a symptom tracking application <ref type="bibr" target="#b29">[31]</ref> about improved mortality in a research letter <ref type="bibr" target="#b34">[36]</ref>.</s><s xml:id="_z6zfZUs">The lack of detail makes evaluation of this publication challenging.</s></p><p xml:id="_JmQANJP"><s xml:id="_6Ukdzb3">Health-economic outcomes These were not explicitly evaluated, but outpatient appointments and readmissions to hospital provide some surrogate outcomes for financial impact <ref type="bibr" target="#b20">[22,</ref><ref type="bibr" target="#b27">29,</ref><ref type="bibr" target="#b29">31]</ref> with one study quoting higher <ref type="bibr" target="#b20">[22]</ref> and one lower hospitalisation rate <ref type="bibr" target="#b29">[31]</ref>.</s></p><p xml:id="_QzmVxCX"><s xml:id="_9E945dA">Adverse effects Adverse effects from using the applications were reported in two studies: higher readmission rates in a study of an existing provider portal <ref type="bibr" target="#b20">[22]</ref> and increased Support Care Cancer (2020) anxiety and distress levels in an application with information about breast cancer <ref type="bibr" target="#b23">[25]</ref>.</s></p><p xml:id="_b9uCVkG"><s xml:id="_awHq9By">Others A single study focused on the detection of cancer relapse in lung cancer survivors <ref type="bibr" target="#b28">[30]</ref>: the study looking at detection of lung cancer relapse using sentinel questionnaires.</s><s xml:id="_4KeBzHn">On average, relapses were found 5 weeks earlier than the planned follow-up visit, and there was a high sensitivity for detection in relapse, but the intervention did not identify a single relapse that was not also detected by sentinel follow-up.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mnfeDZM">Methodological considerations</head><p xml:id="_znwh5cp"><s xml:id="_WXm26kr">Studies had clearly documented inclusion criteria and methodology.</s><s xml:id="_cpNgv3t">All applications using symptom reporting used validated and peer-reviewed scales.</s><s xml:id="_KVRv8M7">While ten of the studies were randomized, for obvious reasons none of them were blinded.</s><s xml:id="_hHPGDCP">Education status and familiarity with internet/mobile technology improved outcomes <ref type="bibr" target="#b29">[31]</ref> in one study but not in another <ref type="bibr" target="#b24">[26]</ref>.</s><s xml:id="_Tctu3Bx">Patients used the interventions in varying amounts, but little data were available on the 'dosage' of application usage.</s><s xml:id="_gxThGKr">Increased usage might perceivably lead to improved outcomes.</s><s xml:id="_geSWVjf">A 'prescribed dose' of intervention would facilitate evaluation but would be unrealistic as patients will experience symptoms in varying amounts and will therefore need their intervention in varying amounts <ref type="bibr" target="#b21">[23]</ref>.</s><s xml:id="_ePKkyzv">Some measure of compliance was included in most studies whereas acceptability was only formally assessed in three studies (Table <ref type="table" target="#tab_1">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_MXJhrbs">Applicability of results to patients undergoing routine oncology care</head><p xml:id="_PeaH88F"><s xml:id="_FV8bjpX">Studies identified covered a wide range of ages and demonstrated that both young people and the older generation were comfortable using apps.</s><s xml:id="_68sz7Wp">Some of the used measurement tools referred to a specific malignancy, and extrapolation of results does therefore need to be with caution.</s><s xml:id="_JzUPSyB">Variation in sample size means that results from studies with smaller patient groups might be context sensitive and not be applicable without further testing in other clinical settings.</s></p><p xml:id="_fpBP4X9"><s xml:id="_KZUE8AQ">While self-reported outcomes may be subject to some recall bias <ref type="bibr" target="#b26">[28]</ref>, many of the applications allowed for in the moment reporting <ref type="bibr" target="#b21">[23,</ref><ref type="bibr" target="#b35">37]</ref> which is likely to have less recall bias than waiting to inform a medical practitioner in an outpatient or clinic setting.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Q9Jz3TH">Safety aspects</head><p xml:id="_GEXUxMn"><s xml:id="_Cw4QUsb">Several of the applications described alert systems which informed a healthcare professional if further intervention was required, potentially improving patient safety and increasing communication between patient and healthcare providers.</s><s xml:id="_KD2RKut">One application facilitated discussion between healthcare providers and patient by educating the patient on how best to communicate their concern prior to a clinic appointment <ref type="bibr" target="#b31">[33]</ref>.</s><s xml:id="_CCCZyG2">Response to new symptoms was at times delayed: In 'SIST-net' 74% percent of new symptoms reported by patients were addressed by a nurse practitioner in under three working days; this was below the pre-set target of 90%, thus highlighting potential workload implications and the need to put robust failsafe mechanism in place to follow up reported symptoms <ref type="bibr" target="#b27">[29]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_eAVRcrr">Discussion</head><p xml:id="_WneCUbt"><s xml:id="_vZqk5G6">The authors have identified a small number of mHealth applications that have been examined in clinical studies with a randomized or non-randomized control group.</s><s xml:id="_RhyhHyU">Studies identified were aimed at a range of different cancers and age groups.</s><s xml:id="_GWBAG63">Positive impact was largely limited to improved symptom control, but several studies reported increased symptoms.</s><s xml:id="_nn73VXz">Data on other outcomes including health economic measures were limited.</s></p><p xml:id="_7fJn36d"><s xml:id="_DAfSXwH">Our search is limited by several factors: In patients with cancer changes in clinical status, morbidity and mortality can be expected within months, but the sample size of most studies might have precluded significant numbers within the study duration.</s><s xml:id="_Gdr4nNA">Only one of the studies examined impact on mortality <ref type="bibr" target="#b34">[36]</ref>; however, since the longest study was only conducted for 12 months, there is at current lack of long-term data.</s></p><p xml:id="_6mPdya4"><s xml:id="_GtTtYRG">Friends, family, and other carers are often able to identify deviation from a patient's normal status as a first step to facilitate calls for help.</s><s xml:id="_5twE4tC">Only one study 'pain buddy', an avatarbased symptom dairy/pain management application, invited a family member to also engage with the application, so this is a potentially unique or underexplored feature <ref type="bibr" target="#b35">[37]</ref>.</s></p><p xml:id="_kpRe392"><s xml:id="_6Qea4wJ">The majority of studies identified were randomized controlled trial.</s><s xml:id="_xh8AP8M">Given the fast pace of innovation in digital technology, this might not be the best methodology to evaluate impact <ref type="bibr" target="#b36">[38]</ref>.</s><s xml:id="_2M8jPy3">Smartphone applications are only one of the new digital ways to provide care with smart watches <ref type="bibr" target="#b37">[39,</ref><ref type="bibr" target="#b38">40]</ref> and telehealth <ref type="bibr" target="#b39">[41,</ref><ref type="bibr" target="#b40">42]</ref> offering alternatives to traditional models of care.</s></p><p xml:id="_mz2PMwG"><s xml:id="_k4mYShP">The reasons for the limited evidence for mHealth applications in cancer might be complex: mHealth applications are a relative new addition to the armamentarium of clinicians, but safety implications are potentially considerable.</s><s xml:id="_Qb7vs3D">The novelty means that principles of design and implementation are not as clear as those used for pharmacological interventions.</s><s xml:id="_PrkwcMS">Mobile applications for medical purposes require compliance with regulations and the obligation to updating information.</s><s xml:id="_nEzhc8W">A review of mHealth applications for patients with cancer in Spain found that only half had been developed by healthcare organisations <ref type="bibr" target="#b46">[48]</ref>.</s><s xml:id="_3ntzNu7">The potential lack of clinical input into the development might be one reason for limited clinical impact despite the considerable promise of applications to monitor toxicity <ref type="bibr" target="#b24">[26]</ref> or even adjust chemotherapy drug dosing for safety impact <ref type="bibr" target="#b47">[49]</ref>.</s></p><p xml:id="_DH24Tp2"><s xml:id="_yPmE6Jz">The present search identified registered trials that might help for further insights into the impact of mHealth interventions in the near future: eRapid is a system for patients to 'selfreport and manage adverse events online during and after cancer treatment'.</s><s xml:id="_Z5gAFev">The platform has been developed with patients <ref type="bibr" target="#b41">[43,</ref><ref type="bibr" target="#b42">44]</ref>.</s><s xml:id="_r77XQDc">Field testing has been completed <ref type="bibr" target="#b43">[45]</ref>, and the related randomized controlled trial is powered against symptom control but will include the number of hospital, primary care, and community contacts.</s></p><p xml:id="_uAw6mNu"><s xml:id="_bvfrxM3">The eSMART trial will study an application for symptom management in a European multi-centre study to assist patients receiving chemotherapy for breast, colorectal, or haematological cancer <ref type="bibr" target="#b44">[46]</ref>.</s><s xml:id="_n4NPpAJ">PRISMS will attempt a similar intervention in an Australian trial of patients with haematological malignancies <ref type="bibr" target="#b45">[47]</ref>.</s></p><p xml:id="_uZD2uxx"><s xml:id="_Yu2nvuX">Patients with cancer are in principle willing to embrace application assisted care <ref type="bibr" target="#b48">[50]</ref>: A survey of patients with prostate cancer found that out of 375 participants, about half were willing to use a cancer care-assisted app and 72% of these said data protection/pseudonymisation was important.</s><s xml:id="_rRCrknC">A third of the participants who were not willing to use an application cited that secure data transfer and data storage were a concern.</s></p><p xml:id="_D29chrP"><s xml:id="_hfjFVh6">The mHealth application opens the possibility of roundthe-clock care where e-alerts generated from the app can be monitored and acted upon by a member of the cancer specialist team.</s><s xml:id="_ga8mPBx">In practice, out-of-hours services might not be robust enough to accommodate round-the-clock monitoring in many areas.</s><s xml:id="_SdNhnXx">While the ability for applications to facilitate improved communication and red flag alerting with health services, care needs to be made to ensure patients understand that the app is not a replacement for usual care but an adjunct <ref type="bibr" target="#b49">[51]</ref>.</s></p><p xml:id="_Z9eNDWD"><s xml:id="_bFA8Vfb">MHealth interventions work in part through changing communication patterns between patients and their care network.</s><s xml:id="_saZ24Q6">Randomized controlled trials might not be the most suitable way to test complex multi-faceted interventions that are difficult to blind.</s><s xml:id="_Pt5MuTJ">Studies using patient registries might provide an alternative way to evaluate this type of intervention <ref type="bibr" target="#b50">[52,</ref><ref type="bibr" target="#b51">53]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_8ZQH3bm">Conclusions</head><p xml:id="_cTujrpE"><s xml:id="_D2yQngs">The CAT review was based on service consideration in the unit of the authors that provides care for patients in rural and remote areas in North Wales: This review found only a small number of studies measuring outcomes relevant to the PICO question despite a broad search string and multiple databases.</s><s xml:id="_BsnT5XC">Many of the screened studies looked exclusively at the design, feasibility and acceptance of mobile health applications, but there was a significant lack of evidence for the efficacy of utilizing patient-facing applications to improve clinically relevant outcomes.</s><s xml:id="_P5TepSm">More in-depth studies are needed with larger cohorts to fully evaluate the impact of applications to improve patient outcomes.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1</head><label>1</label><figDesc><div><p xml:id="_Dtk9hkk"><s xml:id="_8Jaztfg">Fig. 1 PRISMA flow diagram of literature search</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 2</head><label>2</label><figDesc><div><p><s xml:id="_5UkU9hM">28:1469-1479 1471Functionality of applications, inclusion criteria, outcome measures and results of studies testing mHealth applications for patients with cancer</s></p></div></figDesc><table><row><cell>IdenƟficaƟon</cell><cell>Records idenƟfied through database searching (n=145)</cell><cell cols="2">AddiƟonal records idenƟfied through other sources (n=7)</cell></row><row><cell></cell><cell cols="2">Records aŌer duplicates removed</cell></row><row><cell></cell><cell cols="2">(n=152 minus 13 duplicates)</cell></row><row><cell>Screening</cell><cell cols="2">Records screened</cell></row><row><cell></cell><cell>(n=139)</cell><cell></cell><cell>Records excluded</cell></row><row><cell></cell><cell></cell><cell></cell><cell>(n=98)</cell></row><row><cell>Assessed</cell><cell cols="2">Full-text arƟcles assessed for eligibility (n=42)</cell><cell>Full-text arƟcles excluded: Purely a feasibility study (n=5) Protocols (n=5) Review arƟcle not study (n=1)</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Irrelevant, not an applicaƟon or</cell></row><row><cell></cell><cell></cell><cell></cell><cell>not intended for cancer paƟent</cell></row><row><cell></cell><cell></cell><cell></cell><cell>use (n=13)</cell></row><row><cell></cell><cell cols="2">Studies included in</cell></row><row><cell>Included</cell><cell cols="2">qualitaƟve/quanƟtaƟve synthesis (n=17)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 3</head><label>3</label><figDesc><div><p xml:id="_aWHxgNt"><s xml:id="_gdgw5kW">Compliance with and acceptability of mobile health application and potential sources for bias of the results</s></p></div></figDesc><table><row><cell>Bias</cell><cell>Retrospective analysis of activity found that active inpatients were</cell><cell>more likely to be younger, married and non-locals, had higher</cell><cell>disease severity, and received medical treatment</cell><cell>Computer-experienced group received weekly e-mail alerts in ad-</cell><cell>dition to the self-scoring of symptoms during clinic visits.</cell><cell>Intervention group younger</cell><cell>Intervention and usual care completed in the same population.</cell><cell></cell><cell></cell><cell>Small group with a significant proportion of participants that had</cell><cell>low IT familiarity</cell><cell>No formal control group</cell><cell>Different outcomes in patients with different educational status and</cell><cell>cancer type.</cell><cell>Intervention with significant delay, usage of a second dedicated</cell><cell>phone was raised as a problem by participants</cell><cell>Higher drop-out rate at 12 months in the control group</cell><cell></cell><cell>Involvement of a dedicated nurse practitioner who followed up calls</cell><cell>in the intervention group might be responsible for the effect.</cell><cell>Higher drop-out rate in the intervention group limits analysis.</cell><cell></cell><cell>No formal control group. Pilot study</cell><cell></cell><cell></cell><cell>No control group in relation to the clinical outcome and small</cell><cell>sample size.</cell><cell>Control group lower level of education</cell><cell>Different randomisation algorithm in different hospitals, older</cell><cell>control group</cell><cell>Combination of mHealth intervention with dedicated nurse</cell><cell>practitioner</cell><cell>Randomisation procedure not reported. No data on matching of</cell><cell>control and intervention group.</cell></row><row><cell>Compliance with usage Acceptability of intervention</cell><cell>Not reported Not reported</cell><cell></cell><cell></cell><cell>Not reported Not reported</cell><cell></cell><cell>Coaching intervention received in 374/389 Not reported</cell><cell>82% compliance Patients felt 'reassured by knowing that they were</cell><cell>followed by their oncologist using the sentinel</cell><cell>follow-up'.</cell><cell>Not reported Not reported</cell><cell></cell><cell>Unable to report due to technical problems Not reported</cell><cell>Not reported Not reported</cell><cell></cell><cell>Only reported for patients who had no technical Satisfactory acceptability.</cell><cell>problems. Compliance reported at 69%.</cell><cell>28% in intervention group used module on physical Not reported</cell><cell>activity</cell><cell>Not reported (4 patients did not use the service) Not reported</cell><cell></cell><cell>During a 12-week trial participants logged in to the Not reported</cell><cell>application on average 18 days.</cell><cell>Not reported 90% of participants endorsed at least moderate</cell><cell>satisfaction with the Cancer Distress Coach</cell><cell>application</cell><cell>93% compliance 85% found device 'easy to use'</cell><cell></cell><cell>Not reported Not reported</cell><cell>Self-assessed activity using a questionnaire based Likert scales for overall satisfaction, information</cell><cell>tool satisfaction, continuous use intention and intention</cell><cell>to recommend with values from 3.8 to 4.3/5.</cell><cell>Not reported Not reported</cell><cell>Not reported Not reported</cell></row><row><cell>Author (year)</cell><cell>Aljabri D (2018)</cell><cell></cell><cell></cell><cell>Basch E (2015)</cell><cell></cell><cell>Berry D (2015)</cell><cell>Denis F (2014)</cell><cell></cell><cell></cell><cell>Foley N (2016)</cell><cell></cell><cell>Fortier M (2016)</cell><cell>Golsteijn RHJ (2018)</cell><cell></cell><cell>Jibb LA (2017)</cell><cell></cell><cell>Kanera I (2017)</cell><cell></cell><cell>Kolb NA (2018)</cell><cell></cell><cell>Rosen KD (2018)</cell><cell></cell><cell>Smith SK (2016)</cell><cell></cell><cell></cell><cell>Soto-Pere-De-Celis E</cell><cell>(2018)</cell><cell>Sundberg K (2017)</cell><cell>Uhm K (2017)</cell><cell>Wheelock A (2014)</cell><cell>Zou Q (2018)</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xml:id="_pW4Xe5Q"><p xml:id="_cVrCgWs"><s xml:id="_Zb3e36A">Acknowledgements CPS is part funded by an <rs type="funder">Improvement Science Fellowship of the Health Foundation</rs>.</s><s xml:id="_Q3Rc23d">The publication is related to an iGrant from <rs type="institution">Tenovus</rs>.</s></p></div>
<div><head xml:id="_rYahGzc">Compliance with ethical standards</head></div>
			</div>
			<listOrg type="funding">
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_3Xht4JB">Conflict of interest</head><p xml:id="_j9DcZy3"><s xml:id="_8gj8aQt">The authors declare that they have no conflict of interest.</s></p><p xml:id="_C5e7N9H"><s xml:id="_MGsV5GJ">Ethics The study did not involve patients.</s><s xml:id="_xwfP7TH">Ethics approval was not required.</s></p><p xml:id="_xZqyaQN"><s xml:id="_cMu9xwg">Open Access This article is distributed under the terms of the Creative Comm ons Attribution 4.0 International License (<ref type="url" target="http://creativecommons.org/licenses/by/4.0/">http://  creativecommons.org/licenses/by/4.0/</ref>),</s><s xml:id="_KqZFMyU">which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</s></p><p xml:id="_HZgkpGe"><s xml:id="_2fdtYGV">Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_erjx5zk">Emergency oncology: development, current position and future direction in the USA and UK</title>
		<author>
			<persName><forename type="first">T</forename><surname>Cooksley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Rice</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aCSdUZx">Support Care Cancer</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="3" to="7" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cooksley T, Rice T (2017) Emergency oncology: development, current position and future direction in the USA and UK. Support Care Cancer 25(1):3-7</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_HkXGP7h">Supporting people to manage their health : an introduction to patient activation. The King&apos;s Fund</title>
		<author>
			<persName><forename type="first">Helen</forename><forename type="middle">G</forename><surname>Hibbard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_yDy8fNe">new horizons for health through mobile technologies: second global survey on eHealth</title>
		<meeting><address><addrLine>London</addrLine></address></meeting>
		<imprint>
			<publisher>Global Observatory for eHealth series, the World Health Organisation</publisher>
			<date type="published" when="2011">2014. 2011</date>
			<biblScope unit="volume">3</biblScope>
		</imprint>
	</monogr>
	<note type="raw_reference">Hibbard J Helen G (2014) Supporting people to manage their health : an introduction to patient activation. The King&apos;s Fund, London 3. World Health Organization (2011) mHealth: new horizons for health through mobile technologies: second global survey on eHealth Vol. 3, Global Observatory for eHealth series, the World Health Organisation</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main" xml:id="_YduaymF">Mobile health market -trends and figures 2013-2017</title>
		<author>
			<persName><forename type="first">R-G</forename><surname>Jahns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Houck</surname></persName>
		</author>
		<idno type="DOI">10.1787/1a63877a-en</idno>
		<imprint>
			<date type="published" when="2013">2013</date>
			<pubPlace>Berlin</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Jahns R-G, Houck P (2013) Mobile health market -trends and figures 2013-2017. Berlin</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<idno type="DOI">10.1049/esn.1985.0071</idno>
		<ptr target="https://www.bbc.co.uk/news/business-37468560" />
	</analytic>
	<monogr>
		<title level="m" xml:id="_HqwzASh">Has never been more addicted to smartphones</title>
		<imprint>
			<publisher>UK</publisher>
			<date type="published" when="2016-06-21">2016. 21 June 2018</date>
		</imprint>
	</monogr>
	<note>internet cited 2018 Jul 21</note>
	<note type="raw_reference">UK (2016) &quot;Has never been more addicted to smartphones&quot; -BBC news [internet]. [cited 2018 Jul 21]. Available from: https://www. bbc.co.uk/news/business-37468560. Accessed 21 June 2018</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_SKZfu9C">The ownership and clinical use of smartphones by doctors and nurses in the UK: a multicentre survey study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Mobasheri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gautama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Purkayastha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Darzi</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjinnov-2015-000062</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QpMZvjw">BMJ Innov</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="174" to="181" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mobasheri MH, King D, Johnston M, Gautama S, Purkayastha S, Darzi A (2015) The ownership and clinical use of smartphones by doctors and nurses in the UK: a multicentre survey study. BMJ Innov 1(4):174-181</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_Npf3WYr">Evaluating mobile phone applications for health behaviour change: a systematic review</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Mckay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Stephens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Uccellini</surname></persName>
		</author>
		<idno type="DOI">10.1177/1357633x16673538</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hSjGCbT">J Telemed Telecare</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="22" to="30" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McKay FH, Cheng C, Wright A, Shill J, Stephens H, Uccellini M (2018) Evaluating mobile phone applications for health behaviour change: a systematic review. J Telemed Telecare 24(1):22-30</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_SMZXV5w">Mobile applications to improve medication adherence</title>
		<author>
			<persName><forename type="first">J</forename><surname>Haase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Farris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Dorsch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GTnH2zH">Telemed e-Health</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="75" to="79" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Haase J, Farris KB, Dorsch MP (2017) Mobile applications to im- prove medication adherence. Telemed e-Health 23(2):75-79</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_REsH7Sv">What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Iribarren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Falzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Stone</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0170581</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_epQPDMA">PLoS One</title>
		<editor>
			<persName><forename type="first">C</forename><surname>Mihalopoulos</surname></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">170581</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Iribarren SJ, Cato K, Falzon L, Stone PW (2017) What is the eco- nomic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions. Mihalopoulos C, editor. PLoS One 12(2):e0170581</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_SDdxSjX">mHealth technologies for palliative care patients at the interface of inpatient to outpatient care: protocol of feasibility study aiming to early predict deterioration of patient&apos;s health status</title>
		<author>
			<persName><forename type="first">G</forename><surname>Theile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Klaas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tröster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Guckenberger</surname></persName>
		</author>
		<idno type="DOI">10.2196/resprot.7676</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ewtmhVJ">JMIR Res Protoc</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">e142</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Theile G, Klaas V, Tröster G, Guckenberger M (2017) mHealth technologies for palliative care patients at the interface of in- patient to outpatient care: protocol of feasibility study aiming to early predict deterioration of patient&apos;s health status. JMIR Res Protoc 6(8):e142</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_ExerGf2">The role of mobile technologies in health care processes: the case of cancer supportive care</title>
		<author>
			<persName><forename type="first">G</forename><surname>Nasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cucciniello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Guerrazzi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hjMC8bH">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">26</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nasi G, Cucciniello M, Guerrazzi C (2015a) The role of mobile technologies in health care processes: the case of cancer supportive care. J Med Internet Res 17(2):e26</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_rpsR9R3">mHealth education applications along the cancer continuum</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Oakley-Girvan</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13187-014-0761-4</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dBUGRaV">J Cancer Educ</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="388" to="394" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Davis SW, Oakley-Girvan I (2015) mHealth education applications along the cancer continuum. J Cancer Educ 30(2):388-394</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_zSksbuK">Patient engagement in cancer survivorship care through mHealth: a consumer-centered review of existing mobile applications</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Geng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Myneni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_S2dWPPb">AMIA Annu Symp Proc AMIA Symp</title>
		<imprint>
			<biblScope unit="volume">2015</biblScope>
			<biblScope unit="page" from="580" to="588" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Geng Y, Myneni S (2015) Patient engagement in cancer survivor- ship care through mHealth: a consumer-centered review of existing mobile applications. AMIA Annu Symp Proc AMIA Symp 2015: 580-588</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_mR7fpan">The performance of mHealth in cancer supportive care: a research agenda</title>
		<author>
			<persName><forename type="first">G</forename><surname>Nasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cucciniello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Guerrazzi</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.3764</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EzBW8yN">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">9</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nasi G, Cucciniello M, Guerrazzi C (2015b) The performance of mHealth in cancer supportive care: a research agenda. J Med Internet Res 17(1):e9</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_Z6KWK9V">A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting</title>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Hollis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wF5r8JM">BMC Health Serv Res</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">211</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chen J, Ou L, Hollis SJ (2013) A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res 13(1):211</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_tdfuK2X">Patientreported outcome measures of the impact of cancer on patients&apos; everyday lives: a systematic review</title>
		<author>
			<persName><forename type="first">S</forename><surname>Catt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Starkings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Shilling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fallowfield</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rMK7SZk">J Cancer Surviv</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="211" to="232" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Catt S, Starkings R, Shilling V, Fallowfield L (2017) Patient- reported outcome measures of the impact of cancer on patients&apos; everyday lives: a systematic review. J Cancer Surviv 11(2):211-232</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_TBUk2Mt">The prognostic significance of patient-reported outcomes in cancer clinical trials</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Gotay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Kawamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bottomley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_huhpQ3K">Artic J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1355" to="1363" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gotay CC, Kawamoto CT, Bottomley A (2008) The prognostic significance of patient-reported outcomes in cancer clinical trials. Artic J Clin Oncol 26:1355-1363</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_4pHteHW">How to write a critically appraised topic: evidence to underpin routine clinical practice</title>
		<author>
			<persName><forename type="first">J</forename><surname>Callander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Anstey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Ingram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Limpens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Flohr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">I</forename><surname>Spuls</surname></persName>
		</author>
		<idno type="DOI">10.1111/bjd.15873</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mbJ6MEk">Br J Dermatol</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1007" to="1013" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Callander J, Anstey AV, Ingram JR, Limpens J, Flohr C, Spuls PI (2017) How to write a critically appraised topic: evidence to under- pin routine clinical practice. Br J Dermatol 177(4):1007-1013</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_f5b7XSx">Quality of life among women diagnosed with breast cancer: a randomized waitlist controlled trial of commercially available mobile app-delivered mindfulness training</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Rosen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Paniagua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kazanis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Potter</surname></persName>
		</author>
		<idno type="DOI">10.1002/pon.4764</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XKjQqQF">Psychooncology</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2023" to="2030" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rosen KD, Paniagua SM, Kazanis W, Jones S, Potter JS (2018) Quality of life among women diagnosed with breast cancer: a randomized waitlist controlled trial of commercially available mobile app-delivered mindfulness training. Psychooncology 27(8):2023-2030</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_wUpyx8D">Short-term efficacy of a computer-tailored physical activity intervention for prostate and colorectal cancer patients and survivors: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">Rhj</forename><surname>Golsteijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bolman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Volders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Peels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>De Vries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lechner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GM9tx66">Int J Behav Nutr Phys Act</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">106</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Golsteijn RHJ, Bolman C, Volders E, Peels DA, de Vries H, Lechner L (2018) Short-term efficacy of a computer-tailored phys- ical activity intervention for prostate and colorectal cancer patients and survivors: a randomized controlled trial. Int J Behav Nutr Phys Act 15(1):106</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_shcP9P4">Health education using telephone and WeChat in treatment of symptomatic uterine myoma with highintensity focused ultrasound</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Zou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<idno type="DOI">10.12659/msmbr.911040</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JveTYVf">Med Sci Monit Basic Res</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="127" to="133" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zou Q, Zhang G, Liu Y (2018) Health education using telephone and WeChat in treatment of symptomatic uterine myoma with high- intensity focused ultrasound. Med Sci Monit Basic Res 24:127-133</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_HpTH9jv">Patient portal adoption and use by hospitalized cancer patients: a retrospective study of its impact on adverse events, utilization, and patient satisfaction</title>
		<author>
			<persName><forename type="first">D</forename><surname>Aljabri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dumitrascu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Burton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Xirasagar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Horner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Naessens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VM5tXhb">BMC Med Inform Decis Mak</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">70</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Aljabri D, Dumitrascu A, Burton MC, White L, Khan M, Xirasagar S, Horner R, Naessens J (2018) Patient portal adoption and use by hospitalized cancer patients: a retrospective study of its impact on adverse events, utilization, and patient satisfaction. BMC Med Inform Decis Mak 18(1):70</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_czcNYV4">Implementation and preliminary effectiveness of a realtime pain management smartphone app for adolescents with cancer: a multicenter pilot clinical study</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Jibb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Nathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Seto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cafazzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Johnston</surname></persName>
		</author>
		<idno type="DOI">10.1002/pbc.26554</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EUqj4gc">Pediatr Blood Cancer</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jibb LA, Stevens BJ, Nathan PC, Seto E, Cafazzo JA, Johnston DL et al (2017) Implementation and preliminary effectiveness of a real- time pain management smartphone app for adolescents with cancer: a multicenter pilot clinical study. Pediatr Blood Cancer 64(10):1-9</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_N8MYjtQ">Cancer distress coach: pilot study of a mobile app for managing posttraumatic stress</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kuhn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Donnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Koontz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Molloy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename></persName>
		</author>
		<idno type="DOI">10.1002/pon.4363</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3WdndfV">Psychooncology</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="350" to="353" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Smith SK, Kuhn E, O&apos;Donnell J, Koontz BF, Nelson N, Molloy K et al (2018) Cancer distress coach: pilot study of a mobile app for managing posttraumatic stress. Psychooncology 27(1):350-353</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_xNNDcYc">PATI: patient accessed tailored information: a pilot study to evaluate the effect on preoperative breast cancer patients of information delivered via a mobile application</title>
		<author>
			<persName><forename type="first">N</forename><surname>Foley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Connell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lehane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Livingstone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Maher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.breast.2016.08.012</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_euuphqC">Breast</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="54" to="58" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Foley N, O&apos;Connell E, Lehane E, Livingstone V, Maher B, S K et al (2016a) PATI: patient accessed tailored information: a pilot study to evaluate the effect on preoperative breast cancer patients of infor- mation delivered via a mobile application. Breast 30:54-58</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_whhDAy8">A pilot study of an accelerometer-equipped smartphone to monitor older adults with cancer receiving chemotherapy in Mexico</title>
		<author>
			<persName><forename type="first">E</forename><surname>Soto-Perez-De-Celis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Rojo-Castillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C-L</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chavarri-Guerra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Navarrete-Reyes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ea7UDBv">J Geriatr Oncol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="145" to="151" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Soto-Perez-De-Celis E, Kim H, Rojo-Castillo MP, Sun C-L, Chavarri-Guerra Y, Navarrete-Reyes AP et al (2018) A pilot study of an accelerometer-equipped smartphone to monitor older adults with cancer receiving chemotherapy in Mexico. J Geriatr Oncol 9(2):145-151</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_EFSJGP3">Effects of exercise intervention in breast cancer patients: is mobile health (mHealth) with pedometer more effective than conventional program using brochure?</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Uhm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Yoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Kim</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10549-016-4065-8</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9Ja8wWa">Breast Cancer Res Treat</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="443" to="452" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Uhm KE, Yoo JS, Chung SH, Lee JD, Lee I, Kim JI et al (2017) Effects of exercise intervention in breast cancer patients: is mobile health (mHealth) with pedometer more effective than conventional program using brochure? Breast Cancer Res Treat 161(3):443-452</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_bDj544k">Long-term effects of a web-based cancer aftercare intervention on moderate physical activity and vegetable consumption among early cancer survivors: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Kanera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Willems</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Caw</forename><surname>Bolman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Mesters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Verboon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lechner</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12966-017-0474-2</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ksG6Ar5">Int J Behav Nutr Phys Act</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">19</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kanera IM, Willems RA, Bolman CAW, Mesters I, Verboon P, Lechner L (2017) Long-term effects of a web-based cancer after- care intervention on moderate physical activity and vegetable consumption among early cancer survivors: a randomized con- trolled trial. Int J Behav Nutr Phys Act 14(1):19</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_J3PaGeT">SIS.NET: a randomized controlled trial evaluating a web-based system for symptom management after treatment of breast cancer</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Wheelock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Bock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Martin</forename><forename type="middle">El</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Rugo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rN8afy8">Cancer</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="893" to="899" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wheelock AE, Bock MA, Martin EL, Hwang J, Lou EM, Rugo HS et al (2015) SIS.NET: a randomized controlled trial evaluating a web-based system for symptom management after treatment of breast cancer. Cancer 121(6):893-899</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_8Tqx8Wg">Detection of lung cancer relapse using selfreported symptoms transmitted via an internet web-application: pilot study of the sentinel follow-up</title>
		<author>
			<persName><forename type="first">F</forename><surname>Denis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Viger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Charron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Voog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Dupuis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Pointreau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Letellier</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00520-013-2111-1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VGYBMsB">Support Care Cancer</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1467" to="1473" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Denis F, Viger L, Charron A, Voog E, Dupuis O, Pointreau Y, Letellier C (2014) Detection of lung cancer relapse using self- reported symptoms transmitted via an internet web-application: pi- lot study of the sentinel follow-up. Support Care Cancer 22(6): 1467-1473</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_Nx3EDtj">Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">E</forename><surname>Basch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Deal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Kris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">I</forename><surname>Scher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Hudis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sabbatini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Rogak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Dueck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Atkinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dulko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Barz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Novotny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fruscione</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Sloan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schrag</surname></persName>
		</author>
		<idno type="DOI">10.1200/jco.2015.63.0830</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pcuRCaG">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="557" to="565" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D (2016) Symptom monitoring with patient-reported outcomes during rou- tine cancer treatment: a randomized controlled trial. J Clin Oncol 34(6):557-565</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_YpuHdJn">Early detection and management of symptoms using an interactive smartphone application (Interaktor) during radiotherapy for prostate cancer</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sundberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wengström</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Blomberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hälleberg-Nyman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Frank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Langius-Eklöf</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00520-017-3625-8</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qQtMUTX">Support Care Cancer</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="2195" to="2204" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sundberg K, Wengström Y, Blomberg K, Hälleberg-Nyman M, Frank C, Langius-Eklöf A (2017) Early detection and management of symptoms using an interactive smartphone application (Interaktor) during radiotherapy for prostate cancer. Support Care Cancer 25(7):2195-2204</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_DK4u89j">The electronic self report assessment and intervention for cancer: promoting patient verbal reporting of symptom and quality of life issues in a randomized controlled trial</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Berry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Halpenny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Partridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Fann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wolpin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>Lober</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Parvathaneni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Amtmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jvHnd99">BMC Cancer</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">513</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Berry DL, Hong F, Halpenny B, Partridge A, Fox E, Fann JR, Wolpin S, Lober WB, Bush N, Parvathaneni U, Amtmann D, Ford R (2014) The electronic self report assessment and interven- tion for cancer: promoting patient verbal reporting of symptom and quality of life issues in a randomized controlled trial. BMC Cancer 14(1):513</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_B8bNUje">Chemotherapy-related neuropathic symptom management: a randomized trial of an automated symptom-monitoring system paired with nurse practitioner follow-up</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Kolb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Singleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Howard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dittus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Karafiath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mooney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XrRGGWT">Support Care Cancer</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1607" to="1615" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kolb NA, Smith AG, Singleton JR, Beck SL, Howard D, Dittus K, Karafiath S, Mooney K (2018) Chemotherapy-related neuropathic symptom management: a randomized trial of an automated symptom-monitoring system paired with nurse practitioner fol- low-up. Support Care Cancer 26(5):1607-1615</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_fKv88kF">PATI: patient accessed tailored information: a pilot study to evaluate the effect on preoperative breast cancer patients of information delivered via a mobile application</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Foley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Connell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Lehane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Livingstone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Maher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kaimkhani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.breast.2016.08.012</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WCukU39">Breast</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="54" to="58" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Foley NM, O&apos;Connell EP, Lehane EA, Livingstone V, Maher B, Kaimkhani S et al (2016b) PATI: patient accessed tailored informa- tion: a pilot study to evaluate the effect on preoperative breast can- cer patients of information delivered via a mobile application. Breast 30:54-58</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_DNXE6JP">Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment</title>
		<author>
			<persName><forename type="first">E</forename><surname>Basch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Deal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Dueck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">I</forename><surname>Scher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Kris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hudis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schrag</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2017.7156</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6bA4AMc">JAMA</title>
		<imprint>
			<biblScope unit="volume">318</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="197" to="198" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, Schrag D (2017) Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA 318(2):197-198</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_BC9kr9j">Pain buddy: a novel use of m-health in the management of children&apos;s cancer pain</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Fortier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gago-Masague</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sender</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5rAs6jQ">Comput Biol Med</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="202" to="214" />
			<date type="published" when="2016-12">2016. December</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fortier MA, Chung WW, Martinez A, Gago-Masague S, Sender L (2016) Pain buddy: a novel use of m-health in the management of children&apos;s cancer pain. Comput Biol Med 76(December):202-214</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_9YSxaMr">Beyond the randomized controlled trial: a review of alternatives in mHealth clinical trial methods</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Pham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wiljer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cafazzo</surname></persName>
		</author>
		<idno type="DOI">10.2196/mhealth.5720</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_494mm9Z">JMIR mHealth uHealth</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">e107</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pham Q, Wiljer D, Cafazzo JA (2016) Beyond the randomized controlled trial: a review of alternatives in mHealth clinical trial methods. JMIR mHealth uHealth 4(3):e107</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_xwG9hUh">Kick LL: A smartwatch for monitoring respiration and heart rate using photoplethysmography</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">S</forename><surname>Hoilett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Twibell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Srivastava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Linnes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cc6D2MB">Conf Proc IEEE Eng Med Biol Soc</title>
		<imprint>
			<biblScope unit="page" from="3821" to="3824" />
			<date type="published" when="2018">2018. 2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hoilett OS, Twibell AM, Srivastava R, Linnes JC (2018) Kick LL: A smartwatch for monitoring respiration and heart rate using photoplethysmography. Conf Proc IEEE Eng Med Biol Soc 2018: 3821-3824</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_r3ANzrd">Effectiveness of combined smartwatch and social media intervention on breast cancer survivor health outcomes: a 10-week pilot randomized trial</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Pope</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Gao</surname></persName>
		</author>
		<idno type="DOI">10.3390/jcm7060140</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uVfCMVz">J Clin Med</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">140</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pope Z, Zeng N, Zhang R, Lee H, Gao Z (2018) Effectiveness of combined smartwatch and social media intervention on breast can- cer survivor health outcomes: a 10-week pilot randomized trial. J Clin Med 7(6):140</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_h8QX47v">Cancer survivors&apos; experience with telehealth: a systematic review and thematic synthesis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lucas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Marcu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Piano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Grosvenor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Maguire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ream</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.6575</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6SQXWHQ">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cox A, Lucas G, Marcu A, Piano M, Grosvenor W, Mold F, Maguire R, Ream E (2017) Cancer survivors&apos; experience with telehealth: a systematic review and thematic synthesis. J Med Internet Res 19(1):e11</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_quXZs2b">The use of telemedicine to enhance secondary care: some lessons from the front line</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">E</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Elghenzai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Subbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Wyatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Williams</surname></persName>
		</author>
		<idno type="DOI">10.7861/futurehosp.4-2-109</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MUxrpXH">Futur Hosp J</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="109" to="114" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Williams OE, Elghenzai S, Subbe C, Wyatt JC, Williams J (2017) The use of telemedicine to enhance secondary care: some lessons from the front line. Futur Hosp J 4(2):109-114</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_WuvFt4T">Developing a real-time electronic symptom monitoring system for patients after discharge following cancerrelated surgery</title>
		<author>
			<persName><forename type="first">Knl</forename><surname>Avery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Richards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Portal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Reed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Harding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bamforth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Absolom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'connell</forename><surname>Francischetto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Velikova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Blazeby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TmyKYD6">BMC Cancer</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">463</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Avery KNL, Richards HS, Portal A, Reed T, Harding R, Carter R, Bamforth L, Absolom K, O&apos;Connell Francischetto E, Velikova G, Blazeby JM (2019) Developing a real-time electronic symptom monitoring system for patients after discharge following cancer- related surgery. BMC Cancer 19(1):463</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_TjbCJMN">Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment</title>
		<author>
			<persName><forename type="first">P</forename><surname>Holch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Warrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lca</forename><surname>Bamforth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Keding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Ziegler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Absolom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hector</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Harley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Velikova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dRdyr6r">Ann Oncol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2305" to="2311" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Holch P, Warrington L, Bamforth LCA, Keding A, Ziegler LE, Absolom K, Hector C, Harley C, Johnson O, Hall G, Morris C, Velikova G (2017) Development of an integrated electronic plat- form for patient self-report and management of adverse events dur- ing cancer treatment. Ann Oncol 28(9):2305-2311</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_7dErnpK">Online tool for monitoring adverse events in patients with cancer during treatment (eRAPID): field testing in a clinical setting</title>
		<author>
			<persName><forename type="first">L</forename><surname>Warrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Absolom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Holch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Clayton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Velikova</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2018-025185</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uFdjhtY">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">25185</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Warrington L, Absolom K, Holch P, Gibson A, Clayton B, Velikova G (2019) Online tool for monitoring adverse events in patients with cancer during treatment (eRAPID): field testing in a clinical setting. BMJ Open 9(1):e025185</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_5tKuV3m">The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer</title>
		<author>
			<persName><forename type="first">R</forename><surname>Maguire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mccann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Miaskowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kotronoulas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Furlong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ream</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Armes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Patiraki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gaiger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Berg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Flowerday</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Donnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mccrone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Apostolidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Katsaragakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Buick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kearney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QNPRsdZ">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">15016</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Maguire R, Fox PA, McCann L, Miaskowski C, Kotronoulas G, Miller M, Furlong E, Ream E, Armes J, Patiraki E, Gaiger A, Berg GV, Flowerday A, Donnan P, McCrone P, Apostolidis K, Harris J, Katsaragakis S, Buick AR, Kearney N (2017) The eSMART study protocol: a randomised controlled trial to evaluate electronic symp- tom management using the advanced symptom management sys- tem (ASyMS) remote technology for patients with cancer. BMJ Open 7(5):e015016</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_crG3wRf">The Patient Remote Intervention and Symptom Management System (PRISMS)a telehealth-mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies: study protocol for a randomised controlled trial</title>
		<author>
			<persName><forename type="first">S</forename><surname>Breen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ritchie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schofield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hsueh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Santamaria</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13063-015-0970-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rVm652Y">Trials</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">472</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Breen S, Ritchie D, Schofield P, Hsueh Y, Gough K, Santamaria N et al (2015) The Patient Remote Intervention and Symptom Management System (PRISMS) -a telehealth-mediated interven- tion enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies: study protocol for a randomised controlled trial. Trials 16(1):472</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_BbZKDP5">Smartphone applications for cancer patients; what we know about them?</title>
		<author>
			<persName><forename type="first">R</forename><surname>Collado-Borrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Escudero-Vilaplana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ribed-Sánchez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ibáñez-García</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Herranz-Alonso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sanjurjo-Sáez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5uf3dAg">Farm Hosp</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="25" to="35" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Collado-Borrell R, Escudero-Vilaplana V, Ribed-Sánchez A, Ibáñez-García S, Herranz-Alonso A, Sanjurjo-Sáez M (2016) Smartphone applications for cancer patients; what we know about them? Farm Hosp 40(1):25-35</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_zh5HP4a">A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoringsupporting patients in their homes</title>
		<author>
			<persName><forename type="first">A</forename><surname>Weaver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Love</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Larsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shanyinde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Waters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Grainger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Shearwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Brooks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tarassenko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_unCKaRP">Support Care Cancer</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2677" to="2685" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Weaver A, Love SB, Larsen M, Shanyinde M, Waters R, Grainger L, Shearwood V, Brooks C, Gibson O, Young AM, Tarassenko L (2014) A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring -supporting patients in their homes. Support Care Cancer 22(10):2677-2685</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_ge5S8SV">Mobile health in oncology: a patient survey about appassisted cancer care</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Kessel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Vogel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kessel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Biedermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Friess</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kwMV8eq">JMIR mHealth uHealth</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">81</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kessel KA, Vogel MM, Kessel C, Bier H, Biedermann T, Friess H et al (2017) Mobile health in oncology: a patient survey about app- assisted cancer care. JMIR mHealth uHealth 5(6):e81</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_beVUX3a">DIGITAL TECHNOLOGY: opportunities and barriers for usage of personal health records in hospitalreport from a workshop of the Health Informatics Unit at the Royal College of Physicians</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Subbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Øvretveit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Quinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Wyatt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PBgNMg5">Futur Hosp J</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="52" to="56" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Subbe CP, Øvretveit J, Quinn N, Wyatt JC (2019) DIGITAL TECHNOLOGY: opportunities and barriers for usage of person- al health records in hospital -report from a workshop of the Health Informatics Unit at the Royal College of Physicians. Futur Hosp J 6(1):52-56</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_pjHy77H">Assessing the nationwide impact of a registry-based randomized clinical trial on cardiovascular practice</title>
		<author>
			<persName><forename type="first">S</forename><surname>Buccheri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sarno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Fröbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gudnason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lagerqvist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lindholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Olivecrona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>James</surname></persName>
		</author>
		<idno type="DOI">10.1161/circinterventions.118.007381</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DDqTak9">Circ Cardiovasc Interv</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">7381</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Buccheri S, Sarno G, Fröbert O, Gudnason T, Lagerqvist B, Lindholm D, Maeng M, Olivecrona G, James S (2019) Assessing the nationwide impact of a registry-based random- ized clinical trial on cardiovascular practice. Circ Cardiovasc Interv 12(3):e007381</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_RhxX478">REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol</title>
		<author>
			<persName><forename type="first">J</forename><surname>Sundh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bornefalk-Hermansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Ahmadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Blomberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Janson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Currow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Mcdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mccaffrey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ekström</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12890-019-0809-7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9zAbDFh">BMC Pulm Med</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">50</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sundh J, Bornefalk-Hermansson A, Ahmadi Z, Blomberg A, Janson C, Currow DC, McDonald CF, McCaffrey N, Ekström M (2019) REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol. BMC Pulm Med 19(1):50</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
